qPCR & Digital PCR Congress
Developments & Potential of qPCR & dPCR as a Tool for Progressing Molecular Biology Research
September 9th – 10th 2013, Hilton Lyon, France
Academics SAVE 30% Industry SAVE 15%. USE DISCOUNT CODE BTI/JN/NN.
Recent advances in digital PCR and a reduction in cost have enabled the barriers that once held up the adoption of the technology to be overcome. A high performance alternative to qPCR providing absolute quantification, improved sensitivity & specificity, higher precision andgreater robustness is now far more accessible. With a recent survey from Frost & Sullivan finding that 30% of non digital PCR users plan topurchase digital PCR in 2013 and with the gene amplification market predicted to grow to $1.9 billion by 2015, this conference provides a timelyopportunity to learn first-hand about dPCR whilst also keeping up to date with latest developments and strategies in qPCR.
Attracting industry & academic experts working in areas such as molecular biology / diagnostics, gene expression, genomics, biomarkers, pathogen detection, GMO, mRNA, NGS, bioinformatics and data management, the conference agenda will examine the latest strategies, developments and case studies using the technologies to further research in areas such as oncology, infectious diseases, vaccines, prenatal diagnosis, diagnostic & clinical applications, microbiology, food microbiology, plant / ecology genomics and other novel applications.
Unlike other meetings, the qPCR & digital PCR Congress will feature 40 international speakers drawn from academia and industry. This unique blending of academia and industry will provide you with the widest possible range of views on qPCR research and also on the developments in digital PCR, as this new technology becomes more widespread. The Congress has been structured to deliver insights into the latest research
through a series of commentaries, panel discussions, case-studies and poster- resentations featuring developments, not just in Human research, but also lant/Ecology, and Food research.
Keith Jerome, Professor and Head, Virology Division, Department of Laboratory Medicine, University of Washington, Associate Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, USA
Philippe Corbisier, Scientific / Technical Project Manager, Joint Research Center, Institute for Reference Materials and Measurements (IRMM), Standards for Innovation and Sustainable Development (SID), European Commission, Belgium
Emiliano Toso, Molecular Biology Head, Merck Serono, Italy
Thierry Bonnevay, Microbiology Platform Head, Sanofi Pasteur, France
Yiu-Lian Fong, Executive Director, Companion Diagnostic Development, Novartis Oncology, USA
Mao Mao, Research Fellow, Oncology Research, Pfizer Worldwide Research and Development, USA
Arndt Schmitz, Founding Scientist, Global Biomarker - Research Biobank, Bayer Pharma AG, Germany
Afif Michel Abdel Nour, Associate Professor, Special Infectious Agents Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
Alberto Bardelli, Department of Oncological Sciences, Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC) University of Torino, Italy
Barbara Brezna, VÚP Food Research Institute, Bratislava, Slovakia
Philip Day, Reader in Quantitative Analytical Genomics, Manchester University, Director of Quantitative Molecular Medicine and Principal Investigator at the Manchester Interdisciplinary Biocentre, UK
Tanja Dreo, Department of Biotechnology and Systems Biology, National Institute of Biology, Slovenia
Pierre Laurent-Puig, Director, Professor Molecular Basis of the Response to
Xenobiotics, Descartes University, France
David Rodríguez-Lázaro, Assistant Professor of Microbiology, University of Burgos, Spain
Michael Ryckelynck, ISIS, University of Strasbourg, France
Anders Ståhlberg, Senior Scientist, Dept of Pathology, University of Gothenburg, Sweden
BioTechniques International Readers Get a Special Reader Discount. Academics SAVE 30% Industry SAVE 15%. USE DISCOUNT CODE BTI/JN/NN.